AI-Integrated Biologic Development Partner

The contract involves a collaboration with Los Alamos National Laboratory to integrate artificial intelligence-designed targeting molecules into the NanoFET platform, aiming to advance next-generation immunotherapies. This subcontract is focused on developing novel biologic therapies by leveraging AI-driven molecular design to enhance precision targeting within the immune system, with the NanoFET platform serving as the delivery and activation mechanism. The work will be performed at the Los Alamos facility with a zip code of 87545, and all activities are expected to align with DOE’s mission in cutting-edge biomedical innovation. The solicitation was posted on June 17, 2026, with a response deadline of December 18, 2026, and falls under the NAICS code 541712 for research and development in the physical, engineering, and life sciences. The contracting entity is Triad, a Department of Energy contractor, and the agreement is structured as a subcontract, indicating the work is part of a larger program driven by federal R&D priorities. There is no set-aside designation specified, and the effort is open to qualified entities capable of advancing AI-biology integration, with an emphasis on scalable, clinically viable immunotherapy platforms.